Glenmede Trust’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,126
| Closed | -$48K | – | 1322 |
|
|
2020
Q3 | $48K | Sell |
3,126
-56
| -2% | -$965 | ﹤0.01% | 1343 |
|
|
2020
Q2 | $57K | Buy |
3,182
+73
| +2% | +$1.29K | ﹤0.01% | 1280 |
|
|
2020
Q1 | $92K | Hold |
3,109
| – | – | ﹤0.01% | 1454 |
|
|
2019
Q4 | $92K | Hold |
3,109
| – | – | ﹤0.01% | 1454 |
|
|
2019
Q3 | $67 | Hold |
3,109
| – | – | ﹤0.01% | 1538 |
|
|
2019
Q2 | $77 | Sell |
3,109
-92
| -3% | -$2.18K | ﹤0.01% | 1491 |
|
|
2019
Q1 | $78 | Sell |
3,201
-156
| -5% | -$3.73K | ﹤0.01% | 1491 |
|
|
2018
Q4 | $61 | Buy |
+3,357
| New | +$79.9K | ﹤0.01% | 1508 |
|
|
2018
Q3 | – | Sell |
-3,162
| Closed | -$73K | – | 1475 |
|
|
2018
Q2 | $73K | Sell |
3,162
-143
| -4% | -$2.96K | ﹤0.01% | 1339 |
|
|
2018
Q1 | $67K | Hold |
3,305
| – | – | ﹤0.01% | 1514 |
|
|
2017
Q4 | $67K | Sell |
3,305
-161
| -5% | -$2.55K | ﹤0.01% | 1514 |
|
|
2017
Q3 | $48K | Sell |
3,466
-609
| -15% | -$9.21K | ﹤0.01% | 1664 |
|
|
2017
Q2 | $44K | Hold |
4,075
| – | – | ﹤0.01% | 1647 |
|
|
2017
Q1 | $44K | Buy |
4,075
+580
| +17% | +$7.98K | ﹤0.01% | 1647 |
|
|
2016
Q4 | $50K | Sell |
3,495
-124
| -3% | -$2.27K | ﹤0.01% | 1607 |
|
|
2016
Q3 | $88K | Buy |
3,619
+34
| +0.9% | +$880 | ﹤0.01% | 1430 |
|
|
2016
Q2 | $71K | Buy |
3,585
+1,593
| +80% | +$45.1K | ﹤0.01% | 1450 |
|
|
2016
Q1 | $52K | Sell |
1,992
-480
| -19% | -$35.5K | ﹤0.01% | 1503 |
|
|
2015
Q4 | $251K | Sell |
2,472
-287
| -10% | -$32.2K | ﹤0.01% | 1114 |
|
|
2015
Q3 | $492K | Buy |
2,759
+55
| +2% | +$12.8K | ﹤0.01% | 902 |
|
|
2015
Q2 | $599K | Buy |
2,704
+504
| +23% | +$112K | ﹤0.01% | 874 |
|
|
2015
Q1 | $436K | Buy |
2,200
+229
| +12% | +$40.6K | ﹤0.01% | 1005 |
|
|
2014
Q4 | $281K | Sell |
1,971
-441
| -18% | -$59.3K | ﹤0.01% | 1157 |
|
|
2014
Q3 | $315K | Sell |
2,412
-983
| -29% | -$117K | ﹤0.01% | 1035 |
|
|
2014
Q2 | $427K | Buy |
3,395
+365
| +12% | +$46.6K | ﹤0.01% | 915 |
|
|
2014
Q1 | $399K | Sell |
3,030
-574
| -16% | -$78.5K | ﹤0.01% | 936 |
|
|
2013
Q4 | $422K | Sell |
3,604
-3,825
| -51% | -$419K | ﹤0.01% | 898 |
|
|
2013
Q3 | $774K | Buy |
7,429
+345
| +5% | +$33.6K | 0.01% | 718 |
|
|
2013
Q2 | $609K | Buy |
+7,084
| New | +$558K | 0.01% | 731 |
|
Other funds holding BHC
PC
VH
GCM
GAM
PIP
Glenmede Trust's BHC Position: Q4 2020 in Review
Glenmede Trust sold out of Bausch Health (BHC) in Q4 2020, closing a stake of 3,126 shares — an estimated $48K sold.
Glenmede Trust first reported a position in BHC in Q2 2013 and held it in 29 quarters. The position peaked at $774K in Q3 2013. 338 funds tracked by Wall St. Rank hold BHC as of Q4 2020.
- Glenmede Trust reported no remaining Bausch Health position as of Q4 2020 after selling out during the quarter.
- Glenmede Trust sold 3,126 Bausch Health shares in Q4 2020, an estimated $48K.
- Glenmede Trust first reported a position in Bausch Health in Q2 2013 and held it in 29 quarters.
- Glenmede Trust's Bausch Health position peaked at $774K in Q3 2013.
- 338 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.
Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.